Key background The United States is in the middle of a weight-loss drug boom thanks to the increasing popularity of GLP-1 medications like Wegovy, Ozempic, and Zepbound, but Alli played a different role in the history of weight-loss medications
*Correspondence: Xiao-Yuan Mao, [email protected] These authors have contributed equally to this work This article was submitted to Neuropharmacology, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Available from: Mousapour P, Tasdighi E, Khalaj A, et al
I mean, there are lots of reasons, right
This comprehensive approach aims to foster long-term healthy habits, leading to sustainable weight loss
Randomization was stratified by baseline fibrosis stage (F2 vs